Results 11 to 20 of about 3,617 (206)

Elevated triglyceride glucose index is associated with advanced cardiovascular kidney metabolic syndrome

Scientific Reports
The cardiovascular kidney metabolic (CKM) syndrome is a dynamic geriatric condition that has received limited research attention regarding its potential associations with the triglyceride glucose (TyG) index.
Lanlan Wu, Zheng Huang
doaj   +2 more sources

Association between triglyceride glucose body mass index and 1 year all cause mortality in stage 4 CKM syndrome patients. [PDF]

Sci Rep
The triglyceride-glucose body mass index (TyG-BMI) is acknowledged as a dependable surrogate biomarker for the evaluation of insulin resistance (IR). Current research indicates a significant correlation between TyG-BMI and the risk of subsequent cardiovascular events in individuals diagnosed with cardiovascular-kidney-metabolic syndrome (CKM) at stages
Pan W, Ji TF, Hu BT, Yang J, Lu L, Wei J.   +5 more
europepmc   +4 more sources

Cardiovascular-Kidney-Metabolic Syndrome: An Update for Clinician [PDF]

Jurnal Penyakit Dalam Indonesia
Cardiovascular-kidney-metabolic (CKM) syndrome is a systemic abnormality resulting from complex pathophysiological interactions among cardiovascular disease, chronic kidney disease, and metabolic risk factors, particularly diabetes mellitus and obesity ...
Muhammad Yamin, Harits Adi Putra
doaj   +3 more sources

Protein-bound uremic toxins as therapeutic targets for cardiovascular, kidney, and metabolic disorders [PDF]

Frontiers in Endocrinology
Cardiovascular-kidney-metabolic (CKM) syndrome is a systemic clinical condition characterized by pathological and physiological interactions among metabolic abnormalities, chronic kidney disease, and cardiovascular diseases, leading to multi-organ ...
Shihan Zhang, Shasha Tang, Yalei Liu, Binghua Xue, Qinyuan Xie, Lingyun Zhao, Huijuan Yuan   +6 more
doaj   +3 more sources

Association Between Serum Advanced Glycation End Products and Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A 3-Year Longitudinal Cohort Study (2019-2022). [PDF]

J Diabetes
ABSTRACTBackgroundCardiovascular‐kidney‐metabolic (CKM) syndrome begins with obesity and glucose abnormalities, advancing to cardiovascular and kidney complications. This study investigates the relationship of advanced glycation end products (AGEs) with CKM syndrome staging and transition patterns.MethodsThis 3‐year longitudinal study (2019–2022) of ...
Zhao H, Zhang ZW, Luo T, Aili D, Ding WH, Li YY, Gu YS, Aslibek S, He JJ, Yu WH, Ma RZ, Gaoshao A, Qiao TT, Zhang GZ, Lynn HS, Du ML, Dai JH.   +16 more
europepmc   +3 more sources

Bilirubin bioconversion to urobilin in the gut-liver-kidney axis: A biomarker for insulin resistance in the Cardiovascular-Kidney-Metabolic (CKM) Syndrome. [PDF]

Metabolism
The rising rates of obesity worldwide have increased the incidence of cardiovascular disease (CVD), making it the number one cause of death. Higher plasma bilirubin levels have been shown to prevent metabolic dysfunction and CVD. However, reducing levels leads to deleterious outcomes, possibly due to reduced bilirubin half-life that escalates the ...
Kipp ZA, Badmus OO, Stec DE, Hall B, Hinds TD.   +4 more
europepmc   +3 more sources

Role of Residual Inflammation as a Risk Factor Across Cardiovascular-Kidney-Metabolic (CKM) Syndrome: Unpacking the Burden in People with Type 2 Diabetes. [PDF]

Diabetes Ther
Type 2 diabetes mellitus (T2DM) is a global health crisis, with cardiovascular disease (CVD) accounting for 75% of mortality in this population. Despite advances in managing traditional risk factors, such as low-density lipoprotein cholesterol (LDL) cholesterol reduction (IMPROVE-IT, FOURIER), antithrombotic therapies (PEGASUS, COMPASS), and ...
Ghafoury R, Malek M, Ismail-Beigi F, Khamseh ME.   +3 more
europepmc   +3 more sources

Exercise rehabilitation in cardiovascular-kidney-metabolic syndrome: a narrative review [PDF]

Frontiers in Cardiovascular Medicine
Cardiovascular-Kidney-Metabolic Syndrome (CKM) is a multi-organ dysfunction syndrome driven by the interaction of metabolic risk factors, chronic kidney disease, and cardiovascular disease, culminating in adverse cardiovascular events.
Min Sun, Min Sun, Zhou Yang, Shijun Xu, Hongyang Liu   +4 more
doaj   +2 more sources

Prevalence and mortality of cardiovascular-kidney-metabolic syndrome in US adults, 1999–2018 [PDF]

American Heart Journal Plus
Background: Cardiovascular-kidney-metabolic (CKM) syndrome is a novel staging construct that reflects the pathophysiological interplay between these individual conditions.
Huzaifa Ahmad Cheema, Abia Shahid, Saad Ur Rahman, Khurram Nasir, Jaideep Patel, Anandita Kulkarni, Janani Rangaswami, Sarju Ganatra, Sourbha S. Dani   +8 more
doaj   +2 more sources

Impact of Lung Function and COPD on the Prevalence and Mortality of CKM Syndrome: Evidence from a Cross-Sectional Study

COPD
Background Chronic obstructive pulmonary disease (COPD) and cardiovascular-kidney-metabolic (CKM) syndrome are major public health concerns, yet their interrelationship remains under-explored.
Jisong Yan, Xingyao Tang, Minghui Shi, Wei Li, Tingting Huang, Yanan Cui, Yaodie Peng, Rui Su, Ting Yang, Ke Huang   +9 more
doaj   +2 more sources